Hepatitis Secondary to an Over-the-Counter Appetite Stimulant: A Case Report

We present the case of a previously healthy 11-year-old boy who developed hepatitis in the setting of regular intake of Apetamin. Apetamin is an appetite stimulant not approved by the United States Food and Drug Administration that contains cyproheptadine, lysine, and multiple B vitamins. It is illegally imported into the United States and can be purchased online. The patient was referred to the gastrointestinal clinic for evaluation of hepatitis based on screening laboratory testing collected during a routine healthcare visit. Laboratory workup revealed elevated transaminases six months after beginning Apetamin and positive anti-smooth muscle antibody. Liver enzymes improved following the discontinuation of Apetamin. The case highlights the potential of dietary supplements to cause hepatic injury and the importance of a thorough history of complementary alternative medication usage.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-11-23
DOI
https://doi.org/10.7759/cureus.74289
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hepatitis Secondary to an Over-the-Counter Appetite Stimulant: A Case Report

Elizabeth Berg, Shankar Neupane
Cureus
Drug-Induced Hepatotoxicity and Protection
article

Hepatitis Secondary to an Over-the-Counter Appetite Stimulant: A Case Report

Elizabeth Berg, Shankar Neupane
article en

Abstract

We present the case of a previously healthy 11-year-old boy who developed hepatitis in the setting of regular intake of Apetamin. Apetamin is an appetite stimulant not approved by the United States Food and Drug Administration that contains cyproheptadine, lysine, and multiple B vitamins. It is illegally imported into the United States and can be purchased online. The patient was referred to the gastrointestinal clinic for evaluation of hepatitis based on screening laboratory testing collected during a routine healthcare visit. Laboratory workup revealed elevated transaminases six months after beginning Apetamin and positive anti-smooth muscle antibody. Liver enzymes improved following the discontinuation of Apetamin. The case highlights the potential of dietary supplements to cause hepatic injury and the importance of a thorough history of complementary alternative medication usage.

CureusVol. 16(11)
Lincoln Medical Center (US), Columbia University (US)
Zero hunger
Openalex Percentile: Top 73%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.